LIANY
Lianbio
Biopharmaceutical company developing and commercializing medicines for cardiovascular, oncology, ophthalmology, and inflammatory diseases
ADRUnderlying: LIANYCUSIP: 53000N108HealthcareCN1 holder
Sponsored ADR — Delisted from Nasdaq, shut down operations in 2024
Recent Activity
2024Q1
1 sell
-3.56M shares
-3.56M shares
Loading more activity...